Raj Mariwala, director, Mariwala Health Initiative, talks about the importance of self-awareness to identify triggers, and how to ensure people at the margins and on the frontlines have their mental health looked after during the Covid-19 pandemic
In the last month, Mukesh Ambani-owned Jio Platforms has raised $10.3 billion or Rs 78,562 crore
It typically takes five years (and about Rs 15 crore for just the first of many phases) to introduce a viable vaccine to market. Companies across India such as Zydus Cadila, Serum Institute and Bharat Biotech are working against the clock to shrink this period down to a few months. Forbes India's Divya Shekhar takes a deep dive into what this rush looks like on the ground and gives us a glimpse into the path ahead in this episode
The Bengaluru-based accelerator has created a dedicated programme to support Indian startups that are aimed at fighting the pandemic, which received over a thousand applications
Companies in India are using diverse technologies to develop a coronavirus vaccine, but even as they race against time, the road to an efficacious solution is neither straight nor short
With most large-scale gatherings on hold for the foreseeable future, the dearth of live events is already taking a psychological toll, not only on those in the industry but on society at large
Previous financial crises gave rise to high-profile companies. The spread of the coronavirus challenges entrepreneurs to meet new needs
Research reports show that domestic airlines face a bleak future due to poor liquidity
India will begin domestic airline operations from May 25, in a 'calibrated manner', the government said
Subodh C Dixit, executive director, Shapoorji Pallonji Engineering & Construction, on the impending shortage of labour in the coming months and why construction companies are staring at huge financial losses
Finance Minister Nirmala Sitharaman has addressed supply side issues with ₹20 lakh crore package, but there is little to boost demand. Experts say these are just support measures in the absence of direct cash infusions